Литература
1. Anderson A.S., Kraus D., Lang R. Cardiovascular complications of malignant carcinoid disease. Am. Heart J. 1997; 134: 693-702.
2. Biorck G., Axen O., Thorson A. Unusual cyanosis in a boy with congenital pulmonary stenosis and tricuspid insufficiency. Fatal outcome after angiocardiography. Am. Heart J. 1952; 44: 143—8.
3. Modlin I.M., SandorA. An analysis of 8305 cases of carcinoid tumors. Cancer. 1997; 79: 813—29.
4. Kulke M.H., Mayer R.J. Carcinoid tumors. N. Engl J. Med. 1999; 340: 858-68.
5. Matter J.E., Connolly H.M., Rubin J., Seward J.B., Modesto K, Pettikka P.A. Factors associated with progression of carcinoid heart disease. N. Engl. J. Med. 2003; 348: 1005-15.
6. Zuetenhorst J.M., Bonfrer J.M., Korse C.M., Bak- ker R., van Tinteren H, Taal B.G. Carcinoid heart disease: the role of urinary 5-hydroxyindoleacetic acid excretion and plasma levels of atrial natriuretic peptide, transforming growth factor-beta and fibroblast growth factor. Cancer. 2003; 97: 1609—15.
7. Gustafsson B.I., Hauso O., Drozdov I., Kidd M., Modlin I.M. Carcinoid heart disease. Int. J. Cardiol. 2008; 129: 318-24.
8. Simula D.V., Edwards W.D., Tazelaar H.D., Connolly H.M., Schaff H.V. Surgical pathology of carcinoid heart disease: a study of 139 valves from 75 patients spanning 20 years. Mayo Clin. Proc. 2002; 77: 139-47.
9. Palaniswamy C., Frishman W.H., Aronow W.S. Carcinoid heart disease. Cardiol. Rev. 2012; 20: 167-76.
10. Mailer J.E., Pellikka P.A., Bernheim A.M., Schaff H.V., Rubin Connolly H.M. Prognosis of carcinoid heart disease: analysis of 200 cases over two decades. Circulation. 2005; 112: 3320—7.
11. McGuire M.R., Pugh D.M., Dunn M.I. Carcinoid heart disease. Restrictive cardiomyopathy as a late complication. J. Kans. Med. Soc. 1978; 79: 661—25.
12. Jonston S.D., Jonston P.W., O’Rource D. Carcinoid constrictive pericarditis. Heart. 1999; 82: 641—3.
13. Topol E.J., Fortuin L.J. Coronary artery spasm and cardiac arrest in carcinoid heart disease. Am. J. Med. 1984; 77: 950-2.
14. Shehata B.M., Thomas J.E., Doudenko-Ruffomy I. Metastatic carcinoid to the conducting system — is it a rare or merely unrecognized manifestation of carcinoid cardiopathy? Arch. Pathol. Lab. Med. 2002; 126: 1538-40.
15. Moyssakis I.E., Rallidis L.S., Guida G.F., Nihoyan- nopoulos P.I. Incidence and evolution of carcinoid syndrome in the heart. J. Heart Valve Dis. 1997; 6: 625-30.
16. Pellikka P.A., Tajik A.J., Khandheria B.K, Seward J.B., Callahan J.A., Pitot H.C. et al. Carcinoid heart disease. Clinical and echocardio- graphic spectrum in 74 patients. Circulation. 1993; 87: 1188-96.
17. Rudski L.G., Lai W.W., Afilalo J., Hua L., Handschumacher M.D., Chandrasekaran K. et al. Guidelines for the echocardiographic assessment of the right heart in adults: a report from the American Society of Echocardiography endorsed by the European Association of Echocardiography, a registered branch of the European Society of Cardiology, and the Canadian Society of Echocardiography. J. Am. Soc. Echocardiogr. 2010; 23: 685-713.
18. Bhattacharyya S., Davar J., Dreyfus G., Caplin M.E. Carcinoid heart disease. Circulation. 2007; 116: 2860-5.
19. Bhattachaiyya S., Toumpanakis C., Burke M., Taylor A.M., Caplin M.E., Davar J. Features of carcinoid heart disease identified by 2- and 3-dimensional echocardiography and cardiac MRI. Circ. Cardiovasc. Imaging. 2010; 3: 103—11.
20. Mansencal N., McKenna W.J., Mitiy E., Beauchet A., Pellerin D., Rougier P. et al. Comparison of prognostic value of tissue Doppler imaging in carcinoid heart disease versus the value in patients with the carcinoid syndrome but without carcinoid heart disease. Am. J. Cardiol. 2010; 105: 527-31.
21. Franzen D., Boldt A., Raute-Kreinsen U, KoeiferR., Erdmann E. Magnetic resonance imaging diagnosis of carcinoid heart disease. Clin. Cardiol. 2009; 32: 92-3.
22. Sandmann H, Pakkal M., Steeds R. Cardiovascular magnetic resonance imaging in the assessment of carcinoid heart disease. Clin. Radiol. 2009; 64: 761-6.
23. Connolly H.M., Nishimura R.A., Smith H.C., Pellikka P.A., Mullany C.J., Kvols L.K Outcome of cardiac surgery for carcinoid heart disease. J. Am. Coll. Cardiol. 1995; 25: 410-6.
24. Mottram P.M., McGaw D.J., Meredith I.T., Peverill R.E., Haiper R. W. Profound hypoxaemia corrected by PFO closure device in carcinoid heart disease. Eur. J. Echocardiogr. 2008; 9: 47—9.
25. Castillo J. G., Filsoufi F., Adams D.H., Raikhelkar J., Zaku B., Fischer G. W. Management of patient undergoing multivalvular surgery for carcinoid heart disease: the role of the anesthetist. Br. J. Anaesth. 2008; 101: 618—26.
